Sakar Healthcare Ltd

NSE: SAKAR · Pharmaceuticals & Biotechnology · 24 announcements

Share price: ₹1,023.90
Market cap: ₹2,278 Cr
Revenue (annual): ₹251.7 Cr
Net profit (annual): ₹30.48 Cr
P/E (TTM): 63.1×Sector 47.4×
Promoter holding: 52.52%-0.34% QoQ
FII holding: 12.13%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Annual General Meeting 2 Regulatory Approval 1 Other Announcement 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

1 Sep 2026 12:04 IST NSE

Regulatory ApprovalAlfa Alert

Sakar Healthcare Regulatory Approval

Sakar Healthcare Limited received 14 oncology product approvals in the EU, UK, and Canada. These approvals for licensed-out products and site variations will drive top-line sales growth.

Read the filing ↗